SPRY Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 33.50%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $27,822,091.20

ARS Pharmaceuticals Insider Trading History Chart

ARS Pharmaceuticals Share Price & Price History

^$9.97

▲ +0.42 (4.40%)

As of 12/4/2025 05:00 PM ET

Days: 30 | 90 | 365

ARS Pharmaceuticals Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/13/2025	Brian Dorsey	COO	Sell	21,828	$8.71	$190,121.88	10,789
11/12/2025	Justin Chakma	Insider	Sell	166,380	$8.87	$1,475,790.60
8/21/2025	Kathleen D. Scott	CFO	Sell	12,500	$15.00	$187,500.00	10,042
8/21/2025	Richard E. Lowenthal	CEO	Sell	50,000	$14.49	$724,500.00	1,196,494
8/20/2025	Sarina Tanimoto	Insider	Sell	37,656	$14.09	$530,573.04	1,247,447
8/19/2025	Sarina Tanimoto	Insider	Sell	12,344	$14.03	$173,186.32	1,285,103
7/1/2025	Eric Karas	Insider	Sell	15,000	$16.99	$254,850.00	10,315
6/27/2025	James E Flynn	Major Shareholder	Sell	740,149	$18.46	$13,663,150.54	4,887,254
6/18/2025	Eric Karas	Insider	Sell	15,000	$16.00	$240,000.00	7,696
5/20/2025	Alexander A. Fitzpatrick	Insider	Sell	102,969	$14.10	$1,451,862.90	89,613
5/20/2025	Brent L. Saunders	Director	Sell	120,000	$14.25	$1,710,000.00
5/20/2025	Kathleen D. Scott	CFO	Sell	50,000	$14.10	$705,000.00	7,424
4/7/2025	Laura Shawver	Director	Sell	50,002	$12.30	$615,024.60	210,346
3/20/2025	Eric Karas	Insider	Sell	10,000	$14.00	$140,000.00	7,696
3/6/2025	Laura Shawver	Director	Sell	49,600	$11.21	$556,016.00	210,346
2/3/2025	Laura Shawver	Director	Sell	50,000	$12.31	$615,500.00	210,346
1/6/2025	Laura Shawver	Director	Sell	50,000	$11.10	$555,000.00	210,346
12/17/2024	Sarina Tanimoto	Insider	Sell	100,000	$11.67	$1,167,000.00	1,098,499
12/13/2024	Justin Chakma	Insider	Sell	27,272	$12.06	$328,900.32	136,380
12/12/2024	Brian Dorsey	COO	Sell	25,000	$12.30	$307,500.00	6,024
12/10/2024	Sarina Tanimoto	Insider	Sell	100,000	$13.16	$1,316,000.00	1,148,499
12/6/2024	Justin Chakma	Insider	Sell	50,000	$14.23	$711,500.00	136,380
12/4/2024	Laura Shawver	Director	Sell	14,772	$13.75	$203,115.00	210,346
12/3/2024	Justin Chakma	Insider	Sell	45,000	$13.19	$593,550.00	136,380
12/2/2024	Laura Shawver	Director	Sell	97,244	$13.56	$1,318,628.64	210,346
11/27/2024	Justin Chakma	Insider	Sell	25,000	$14.39	$359,750.00	136,380
11/25/2024	Justin Chakma	Insider	Sell	32,814	$14.00	$459,396.00	203,566
11/11/2024	James E Flynn	Major Shareholder	Sell	528,456	$18.04	$9,533,346.24	5,274,735
10/16/2024	Kathleen D. Scott	CFO	Sell	12,500	$16.00	$200,000.00	4,949
10/15/2024	Sarina Tanimoto	Insider	Sell	100,000	$14.88	$1,488,000.00	1,298,499
10/8/2024	Richard E. Lowenthal	CEO	Sell	100,000	$13.83	$1,383,000.00	1,346,494
9/18/2024	Eric Karas	Insider	Sell	10,000	$14.00	$140,000.00	5,693
9/17/2024	Richard E. Lowenthal	CEO	Sell	100,000	$12.93	$1,293,000.00	1,398,499
8/26/2024	Peter A. Thompson	Director	Sell	83,695	$13.00	$1,088,035.00
8/23/2024	Peter A. Thompson	Director	Sell	69,500	$13.03	$905,585.00	83,695
8/21/2024	Peter A. Thompson	Director	Sell	407,700	$13.56	$5,528,412.00	544,677
8/20/2024	Brian Dorsey	COO	Sell	50,000	$15.00	$750,000.00	6,024
8/20/2024	Kathleen D. Scott	CFO	Sell	12,500	$16.00	$200,000.00	13,199
8/20/2024	Richard E. Lowenthal	CEO	Sell	100,000	$15.03	$1,503,000.00	1,497,447
8/19/2024	Eric Karas	Insider	Sell	10,000	$14.00	$140,000.00	5,693
7/16/2024	Richard E. Lowenthal	CEO	Sell	100,000	$11.40	$1,140,000.00	1,547,447
7/9/2024	Sarina Tanimoto	Insider	Sell	100,000	$9.62	$962,000.00	1,496,494
6/12/2024	Sarina Tanimoto	Insider	Sell	95,862	$9.15	$877,137.30	1,546,494
6/11/2024	Richard E. Lowenthal	CEO	Sell	4,138	$9.00	$37,242.00	1,594,328
5/16/2024	Sarina Tanimoto	Insider	Sell	89,096	$9.06	$807,209.76	1,597,447
5/15/2024	Richard E. Lowenthal	CEO	Sell	5,147	$9.05	$46,580.35	1,642,193
5/14/2024	Sarina Tanimoto	Insider	Sell	5,757	$9.01	$51,870.57	1,644,574
5/7/2024	Sarina Tanimoto	Insider	Sell	100,000	$9.34	$934,000.00	1,596,494
4/16/2024	Sarina Tanimoto	Insider	Sell	100,000	$9.28	$928,000.00	1,647,447
4/9/2024	Richard E. Lowenthal	CEO	Sell	100,000	$9.28	$928,000.00	1,646,494
3/27/2024	Ra Capital Management, L.P.	Director	Buy	505,954	$9.79	$4,953,289.66	9,958,073
3/25/2024	Ra Capital Management, L.P.	Director	Buy	437,600	$9.06	$3,964,656.00	8,994,374
3/25/2024	Richard E. Lowenthal	CEO	Sell	95,267	$9.12	$868,835.04	1,697,447
3/22/2024	Sarina Tanimoto	Insider	Sell	2,343	$9.02	$21,133.86	1,745,082
3/21/2024	Richard E. Lowenthal	CEO	Sell	472	$9.00	$4,248.00	1,746,099
3/19/2024	Richard E. Lowenthal	CEO	Sell	1,918	$9.03	$17,319.54	1,746,471
3/15/2024	Richard E. Lowenthal	CEO	Sell	96,756	$9.14	$884,349.84	1,696,494
3/14/2024	Sarina Tanimoto	Insider	Sell	444	$9.00	$3,996.00	1,744,789
3/13/2024	Richard E. Lowenthal	CEO	Sell	2,800	$9.00	$25,200.00	1,744,994
2/29/2024	Richard E. Lowenthal	CEO	Sell	3,782	$9.02	$34,113.64	1,746,494
2/28/2024	Sarina Tanimoto	Insider	Sell	98,778	$9.02	$890,977.56	1,747,294
2/26/2024	Sarina Tanimoto	Insider	Sell	700	$9.01	$6,307.00	1,772,750
9/28/2023	Alexander A. Fitzpatrick	Insider	Buy	40,000	$3.62	$144,800.00	42,969
9/21/2023	Ra Capital Management, L.P.	Director	Buy	2,700,000	$3.03	$8,181,000.00	8,556,774
9/1/2023	Laura Shawver	Director	Sell	100,000	$7.71	$771,000.00	210,346
8/29/2023	Ra Capital Management, L.P.	Director	Buy	3,750,000	$6.20	$23,250,000.00	5,856,774
8/4/2023	Laura Shawver	Director	Sell	18,897	$7.06	$133,412.82	210,346
8/2/2023	Laura Shawver	Director	Sell	36,281	$7.09	$257,232.29	210,346
7/6/2023	Laura Shawver	Director	Sell	33,510	$6.34	$212,453.40	210,346
7/3/2023	Laura Shawver	Director	Sell	26,520	$6.72	$178,214.40	210,346
6/1/2023	Laura Shawver	Director	Sell	73,059	$6.80	$496,801.20	210,346
5/9/2023	Laura Shawver	Director	Sell	42,900	$5.31	$227,799.00	210,346

SEC Filings (Institutional Ownership Changes) for ARS Pharmaceuticals (NASDAQ:SPRY)

68.16% of ARS Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

ARS Pharmaceuticals Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/17/2025	Woodline Partners LP	150,936	$1.52M	0.0%	-49.8%	0.153%
11/17/2025	Dark Forest Capital Management LP	50,940	$0.51M	0.0%	N/A	0.052%
11/17/2025	XTX Topco Ltd	143,636	$1.44M	0.1%	+740.3%	0.145%
11/17/2025	Alyeska Investment Group L.P.	390,092	$3.92M	0.0%	+34.5%	0.395%
11/17/2025	Wexford Capital LP	168,238	$1.69M	0.2%	-56.0%	0.170%
11/17/2025	Qube Research & Technologies Ltd	1,034,798	$10.40M	0.0%	N/A	1.047%
11/17/2025	Brevan Howard Capital Management LP	67,212	$0.68M	0.0%	N/A	0.068%
11/17/2025	Casdin Capital LLC	1,600,000	$16.08M	1.3%	N/A	1.619%
11/17/2025	Bamco Inc. NY	1,268,532	$12.75M	0.0%	+3,071.3%	1.283%
11/17/2025	Bank of America Corp DE	272,026	$2.73M	0.0%	-16.4%	0.275%
11/17/2025	Aquatic Capital Management LLC	105,751	$1.06M	0.0%	+117.2%	0.107%
11/17/2025	Alliancebernstein L.P.	2,642,111	$26.55M	0.0%	-30.9%	2.673%
11/14/2025	Creative Planning	27,175	$0.27M	0.0%	-27.7%	0.027%
11/14/2025	Raymond James Financial Inc.	756,347	$7.60M	0.0%	+12.3%	0.765%
11/14/2025	Rubric Capital Management LP	4,500,000	$45.23M	0.5%	+247.5%	4.552%
11/14/2025	Freestone Grove Partners LP	152,197	$1.53M	0.0%	N/A	0.154%
11/14/2025	Deerfield Management Company L.P.	7,503,812	$75.41M	1.2%	-22.8%	7.591%
11/14/2025	California State Teachers Retirement System	44,388	$0.45M	0.0%	+20.0%	0.045%
11/14/2025	ADAR1 Capital Management LLC	59,230	$0.60M	0.1%	N/A	0.060%
11/14/2025	Zurcher Kantonalbank Zurich Cantonalbank	11,662	$0.12M	0.0%	+57.2%	0.012%
11/14/2025	UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC	335,148	$3.37M	0.0%	+2.9%	0.339%
11/14/2025	Two Sigma Investments LP	72,177	$0.73M	0.0%	N/A	0.073%
11/14/2025	Squarepoint Ops LLC	35,856	$0.36M	0.0%	N/A	0.036%
11/14/2025	Diker Management LLC	43,508	$0.44M	0.4%	+6.1%	0.044%
11/14/2025	Quinn Opportunity Partners LLC	125,000	$1.26M	0.1%	+177.8%	0.126%
11/13/2025	Epoch Investment Partners Inc.	89,980	$0.90M	0.0%	+23.6%	0.091%
11/13/2025	Sei Investments Co.	48,112	$0.48M	0.0%	-43.5%	0.049%
11/13/2025	UBS Group AG	659,886	$6.63M	0.0%	-23.9%	0.668%
11/13/2025	BNP Paribas Financial Markets	12,531	$0.13M	0.0%	+105.5%	0.013%
11/13/2025	Franklin Resources Inc.	2,398,012	$24.10M	0.0%	+31.1%	2.426%
11/13/2025	Russell Investments Group Ltd.	6,668	$67K	0.0%	+197.5%	0.007%
11/13/2025	Private Advisor Group LLC	20,582	$0.21M	0.0%	N/A	0.021%
11/13/2025	First Trust Advisors LP	352,943	$3.55M	0.0%	+3.8%	0.357%
11/12/2025	Barclays PLC	228,569	$2.30M	0.0%	-63.3%	0.231%
11/12/2025	Dimensional Fund Advisors LP	178,148	$1.79M	0.0%	-1.3%	0.180%
11/12/2025	Legato Capital Management LLC	39,410	$0.40M	0.0%	-62.2%	0.040%
11/12/2025	Victory Capital Management Inc.	199,153	$2M	0.0%	N/A	0.202%
11/12/2025	Rafferty Asset Management LLC	122,410	$1.23M	0.0%	+51.4%	0.124%
11/12/2025	Quantbot Technologies LP	8,126	$82K	0.0%	N/A	0.008%
11/12/2025	Intech Investment Management LLC	31,514	$0.32M	0.0%	+21.4%	0.032%
11/10/2025	China Universal Asset Management Co. Ltd.	17,323	$0.17M	0.0%	-12.2%	0.018%
11/7/2025	Levin Capital Strategies L.P.	764,294	$7.68M	0.7%	+157.6%	0.773%
11/7/2025	CenterBook Partners LP	512,367	$5.15M	0.3%	N/A	0.518%
11/7/2025	Vanguard Group Inc.	3,500,303	$35.18M	0.0%	+7.3%	3.542%
11/7/2025	Aberdeen Group plc	3,097,022	$31.13M	0.0%	+106.1%	3.134%
11/6/2025	Profund Advisors LLC	26,330	$0.27M	0.0%	+54.1%	0.027%
11/6/2025	ProShare Advisors LLC	13,607	$0.14M	0.0%	-8.7%	0.014%
11/5/2025	American Assets Inc.	55,000	$0.55M	0.2%	N/A	0.056%
11/5/2025	Alps Advisors Inc.	49,600	$0.50M	0.0%	-6.4%	0.050%
11/4/2025	Allianz Asset Management GmbH	26,000	$0.26M	0.0%	-29.0%	0.026%
11/4/2025	Principal Financial Group Inc.	76,884	$0.77M	0.0%	+38.7%	0.078%
11/4/2025	Lisanti Capital Growth LLC	211,189	$2.12M	0.5%	-49.7%	0.214%
11/3/2025	AlphaQuest LLC	45,819	$0.46M	0.0%	+94.7%	0.046%
11/3/2025	Knights of Columbus Asset Advisors LLC	134,476	$1.35M	0.1%	+97.5%	0.136%
11/3/2025	Coastal Bridge Advisors LLC	91,675	$0.92M	0.1%	+5.3%	0.093%
11/3/2025	Hussman Strategic Advisors Inc.	147,000	$1.48M	0.3%	+40.0%	0.149%
11/3/2025	Belpointe Asset Management LLC	18,860	$0.19M	0.0%	+8.9%	0.019%
10/29/2025	FAS Wealth Partners Inc.	200,620	$2.02M	0.1%	+34.5%	0.203%
10/28/2025	Campbell & CO Investment Adviser LLC	60,525	$0.61M	0.0%	N/A	0.061%
10/23/2025	SG Americas Securities LLC	10,105	$0.10M	0.0%	-60.1%	0.010%
10/23/2025	CX Institutional	9,190	$92K	0.0%	N/A	0.009%
10/17/2025	Permanent Capital Management LP	53,341	$0.54M	0.1%	N/A	0.054%
10/15/2025	CWM LLC	2,547	$26K	0.0%	+243.7%	0.003%
10/9/2025	Voya Investment Management LLC	114,853	$1.15M	0.0%	-30.9%	0.116%
9/4/2025	Osaic Holdings Inc.	5,215	$91K	0.0%	+52.8%	0.005%
8/15/2025	Rafferty Asset Management LLC	80,846	$1.41M	0.0%	+7.3%	0.082%
8/15/2025	Rubric Capital Management LP	1,294,878	$22.60M	0.3%	+25.8%	1.318%
8/15/2025	Octagon Capital Advisors LP	1,350,000	$23.56M	5.2%	+116.0%	1.375%
8/15/2025	BNP Paribas Financial Markets	6,097	$0.11M	0.0%	+58.3%	0.006%
8/15/2025	Boothbay Fund Management LLC	75,458	$1.32M	0.0%	N/A	0.077%
8/15/2025	Balyasny Asset Management L.P.	329,073	$5.74M	0.0%	+92.3%	0.335%
8/15/2025	Bamco Inc. NY	40,000	$0.70M	0.0%	N/A	0.041%
8/15/2025	Bank of America Corp DE	325,352	$5.68M	0.0%	-26.8%	0.331%
8/15/2025	Adage Capital Partners GP L.L.C.	1,728,000	$30.15M	0.1%	N/A	1.759%
8/15/2025	Ameriprise Financial Inc.	345,055	$6.02M	0.0%	+231.4%	0.351%
8/14/2025	MPM Bioimpact LLC	1,303,399	$22.74M	3.9%	-0.7%	1.327%
8/14/2025	Raymond James Financial Inc.	673,370	$11.75M	0.0%	-4.7%	0.686%
8/14/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	33,994	$0.60M	0.0%	+3.8%	0.035%
8/14/2025	Alliancebernstein L.P.	3,825,793	$66.76M	0.0%	-2.5%	3.895%
8/14/2025	The Manufacturers Life Insurance Company	34,020	$0.59M	0.0%	+7.8%	0.035%
8/14/2025	Diker Management LLC	41,000	$0.72M	0.7%	+95.2%	0.042%
8/14/2025	FAS Wealth Partners Inc.	149,160	$2.60M	0.2%	+6.9%	0.152%
8/14/2025	Sei Investments Co.	85,082	$1.49M	0.0%	-21.4%	0.087%
8/14/2025	Ardsley Advisory Partners LP	475,000	$8.29M	1.1%	+46.2%	0.484%
8/14/2025	Next Century Growth Investors LLC	622,823	$10.87M	0.8%	N/A	0.634%
8/14/2025	Certuity LLC	10,000	$0.17M	0.0%	N/A	0.010%
8/13/2025	Cresset Asset Management LLC	30,152	$0.53M	0.0%	+6.7%	0.031%
8/13/2025	Marshall Wace LLP	39,914	$0.70M	0.0%	-74.5%	0.041%
8/13/2025	Epoch Investment Partners Inc.	72,780	$1.27M	0.0%	-38.8%	0.074%
8/13/2025	First Trust Advisors LP	340,119	$5.94M	0.0%	N/A	0.346%
8/13/2025	Invesco Ltd.	117,500	$2.05M	0.0%	+292.3%	0.120%
8/13/2025	RiverPark Advisors LLC	5,703	$100K	0.1%	N/A	0.006%
8/12/2025	XTX Topco Ltd	17,093	$0.30M	0.0%	-65.6%	0.017%
8/12/2025	Steward Partners Investment Advisory LLC	128,180	$2.24M	0.0%	+164.4%	0.131%
8/12/2025	Ameritas Investment Partners Inc.	5,598	$98K	0.0%	+16.1%	0.006%
8/12/2025	American Century Companies Inc.	21,114	$0.37M	0.0%	-77.2%	0.021%
8/12/2025	Rhumbline Advisers	81,261	$1.42M	0.0%	+16.5%	0.083%
8/12/2025	Franklin Resources Inc.	1,828,755	$31.91M	0.0%	-1.5%	1.862%
8/12/2025	Legal & General Group Plc	54,825	$0.96M	0.0%	+55.1%	0.056%
8/12/2025	JPMorgan Chase & Co.	34,560	$0.60M	0.0%	+7.3%	0.035%

Data available starting January 2016

ARS Pharmaceuticals, Inc., a biopharmaceutical company, develops treatments for severe allergic reactions. The company is developing neffy, a needle-free and low-dose intranasal epinephrine nasal spray for the emergency treatment of Type I allergic reactions, including anaphylaxis. It serves healthcare professionals, patients, and caregivers. ARS Pharmaceuticals, Inc. was founded in 2015 and is headquartered in San Diego, California.

Today's Range

Now: $9.97

$9.44

$10.02

50 Day Range

MA: $9.36

$6.73

$11.58

52 Week Range

Now: $9.97

$6.66

$18.90

Volume

1,431,706 shs

Average Volume

2,390,232 shs

Market Capitalization

$985.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.82

Who are the company insiders with the largest holdings of ARS Pharmaceuticals?: ARS Pharmaceuticals' top insider shareholders include:
Ra Capital Management, LP (Director)
James E Flynn (Major Shareholder)
Sarina Tanimoto (Insider)
Richard E Lowenthal (CEO)
Peter A Thompson (Director)
Laura Shawver (Director)
Justin Chakma (Insider)
Alexander A Fitzpatrick (Insider)
Kathleen D Scott (CFO)
Brian Dorsey (COO)
Eric Karas (Insider)
Brent L Saunders (Director)
Learn More about top insider investors at ARS Pharmaceuticals.
Who are the major institutional investors of ARS Pharmaceuticals?: ARS Pharmaceuticals' top institutional shareholders include:
Deerfield Management Company L.P. — 7.59%
Rubric Capital Management LP — 4.55%
Vanguard Group Inc. — 3.54%
Aberdeen Group plc — 3.13%
Alliancebernstein L.P. — 2.67%
Franklin Resources Inc. — 2.43%
Learn More about top institutional investors of ARS Pharmaceuticals stock.
Which major investors are selling ARS Pharmaceuticals stock?: In the last quarter, SPRY stock was sold by these institutional investors:
Deerfield Management Company L.P.
Alliancebernstein L.P.
Barclays PLC
Wexford Capital LP
Lisanti Capital Growth LLC
UBS Group AG
Woodline Partners LP
Legato Capital Management LLC
In the last year, company insiders that have sold ARS Pharmaceuticals company stock include:
Ra Capital Management, LP (Director)
James E Flynn (Major Shareholder)
Sarina Tanimoto (Insider)
Richard E Lowenthal (CEO)
Peter A Thompson (Director)
Laura Shawver (Director)
Justin Chakma (Insider)
Alexander A Fitzpatrick (Insider)
Kathleen D Scott (CFO)
Brian Dorsey (COO)
Learn More investors selling ARS Pharmaceuticals stock.
Which major investors are buying ARS Pharmaceuticals stock?: During the last quarter, SPRY stock was purchased by institutional investors including:
Rubric Capital Management LP
Casdin Capital LLC
Aberdeen Group plc
Bamco Inc. NY
Qube Research & Technologies Ltd
Franklin Resources Inc.
CenterBook Partners LP
Levin Capital Strategies L.P.